BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12176449)

  • 1. Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury.
    Waller JR; Metcalfe MS; Nicholson ML
    Transplant Proc; 2002 Aug; 34(5):1481-3. PubMed ID: 12176449
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclosporin A, FK506 and rapamycin on calcineurin phosphatase activity in mouse brain.
    Yu DY; Luo J; Bu F; Zhang W; Wei Q
    IUBMB Life; 2006 Jul; 58(7):429-33. PubMed ID: 16801218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension.
    Zhang W; Victor RG
    Am J Hypertens; 2000 Sep; 13(9):999-1004. PubMed ID: 10981550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
    Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
    Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
    Gregory CR; Pratt RE; Huie P; Shorthouse R; Dzau VJ; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):770-1. PubMed ID: 7679842
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of immunosuppressants, calcineurin inhibition, and blockade of endoplasmic reticulum calcium channels on free fatty acid efflux from the ischemic/reperfused rat cerebral cortex.
    Phillis JW; Diaz FG; O'Regan MH; Pilitsis JG
    Brain Res; 2002 Dec; 957(1):12-24. PubMed ID: 12443975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
    Sharkey J; Butcher SP
    Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
    Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
    J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin regulates ryanodine receptor/Ca(2+)-release channels in rat heart.
    Bandyopadhyay A; Shin DW; Ahn JO; Kim DH
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):61-70. PubMed ID: 11062058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells.
    Ohye H; Sato M; Murao K; Matsubara S; Tokuda M; Takahara J
    Neuroimmunomodulation; 1998; 5(6):309-17. PubMed ID: 9762012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB.
    Alexanian AR; Bamburg JR
    FASEB J; 1999 Sep; 13(12):1611-20. PubMed ID: 10463953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia.
    Waller JR; Murphy GJ; Bicknell GR; Toomey D; Nicholson ML
    Br J Surg; 2002 Nov; 89(11):1390-5. PubMed ID: 12390379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.
    Gregory CR; Huie P; Shorthouse R; Wang J; Rowan R; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):120-1. PubMed ID: 8438246
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin.
    Chávez R; Jamieson N; Takamori S; Nivatvongs S; Pino G; Metcalfe A; Watson C; Romero D; Metcalfe S
    Transplant Proc; 1999 Sep; 31(6):2429. PubMed ID: 10500655
    [No Abstract]   [Full Text] [Related]  

  • 18. The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity.
    Kumar R; Adams B; Musiyenko A; Shulyayeva O; Barik S
    Mol Biochem Parasitol; 2005 Jun; 141(2):163-73. PubMed ID: 15850699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal choline transporter CHT1 is regulated by immunosuppressor-sensitive pathways.
    Guermonprez L; O'Regan S; Meunier FM; Morot-Gaudry-Talarmain Y
    J Neurochem; 2002 Aug; 82(4):874-84. PubMed ID: 12358793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits.
    Tachibana T; Shiiya N; Kunihara T; Wakamatsu Y; Kudo AF; Ooka T; Watanabe S; Yasuda K
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):123-8. PubMed ID: 15632833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.